drugset / Trial / NCT01279577

Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease

NCT01279577 ↗

Phase 2 Completed 254 enrolled Dr. Falk Pharma GmbH
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will run in centers in Germany, Denmark, Austria, Czech Republic, and Switzerland, only. This proof-of-concept study aims to evaluate the efficacy of three doses of oral TSO suspension vs. placebo for the induction of remission in Crohn's disease.

Timeline

Start
2010-11
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Trichuris suis ova Other / unclassified — Oral

Indications